Frontiers in Microbiology Impact Factor

The first signal is breadth. Frontiers in Microbiology is a broad, section-based journal that covers a large share of the microbiology landscape.

The second signal is volume. The journal publishes thousands of papers per year. That matters because a JIF of 4.5 at this scale says something different from a 4.5 JIF at a highly selective low-volume title.

The third signal is stability. The five-year JIF of 5.2 is moderately above the current JIF, which suggests the strongest papers retain value beyond the short initial citation window. But the JCI of 0.98 is basically field average, so this is not a journal whose metric profile says "elite." It says "credible, visible, broad, and real."

The JCR row above is the authoritative impact factor on this page. For the longer directional view, the table below uses the open Scopus-based impact score series as a trend proxy.

Directionally, the open citation signal is up from 4.02 in 2023 to 4.49 in 2024, though still below the 2020 to 2021 peak. That pattern fits a broad high-volume journal that benefited from a heavy-citation microbiology period and then normalized.

The healthier read is that the journal remains a stable, visible option for broad microbiology work, not that it is climbing into the prestige tier.

The common mistake is to treat the number as a quality verdict in either direction.

Some authors see 4.5 and assume the journal is weak. Others see Q1 and assume the journal is much more selective than it is. Both readings miss the actual point.

Frontiers in Microbiology is better understood as:

• broad rather than narrow
• section-owned rather than one single editorial taste
• visible and credible rather than elite
• high-volume rather than highly restrictive

That means fit matters a lot. The journal can work well for the right microbiology paper, but the metric alone does not tell you whether the section, audience, and level are right.

In our pre-submission review work on manuscripts targeting Frontiers in Microbiology, the repeat problem is not usually underpowered data. It is underdeveloped consequence.

The paper may show what organisms are present or what changed, but it still does not explain clearly enough what that change means mechanistically, ecologically, or clinically.

In our pre-submission review work on manuscripts targeting Frontiers in Microbiology, four failure patterns recur.

The paper is descriptive. Sequencing, prevalence, or characterization studies without enough functional consequence often feel incomplete.

The section choice is wrong. A decent manuscript can still have a rough path if it is submitted into the wrong specialty section.

The mechanism is too thin. The journal is broad, but broad does not mean uninterested in causal or functional explanation.

The real audience is narrower than the paper admits. Some manuscripts are better owned by a more specific microbiology venue.

If that sounds like the package, a Frontiers in Microbiology submission readiness check is usually more useful than another round of cosmetic cleanup.

The impact factor does not tell you whether the section fit is right, whether the paper has enough functional consequence, or whether a narrower microbiology journal would give the work a better editorial home.

That is the real decision. The metric describes the journal's visibility, not the manuscript's fit.